A detailed history of Avantax Advisory Services, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 29,134 shares of BSX stock, worth $2.64 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
29,134
Previous 32,848 11.31%
Holding current value
$2.64 Million
Previous $2.53 Million 3.48%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $270,973 - $311,976
-3,714 Reduced 11.31%
29,134 $2.44 Million
Q2 2024

Aug 09, 2024

BUY
$67.33 - $77.71 $1.18 Million - $1.37 Million
17,583 Added 115.19%
32,848 $2.53 Million
Q1 2024

May 08, 2024

BUY
$57.6 - $68.62 $7,430 - $8,851
129 Added 0.85%
15,265 $1.05 Million
Q4 2023

Feb 07, 2024

SELL
$48.64 - $57.81 $40,371 - $47,982
-830 Reduced 5.2%
15,136 $875,000
Q3 2023

Nov 07, 2023

SELL
$50.19 - $54.68 $190,571 - $207,619
-3,797 Reduced 19.21%
15,966 $843,000
Q2 2023

Aug 11, 2023

BUY
$49.72 - $54.64 $59,713 - $65,622
1,201 Added 6.47%
19,763 $1.07 Million
Q1 2023

Apr 28, 2023

BUY
$45.09 - $50.03 $5,320 - $5,903
118 Added 0.64%
18,562 $928,000
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $110,886 - $132,357
2,803 Added 17.92%
18,444 $853,000
Q3 2022

Nov 01, 2022

BUY
$36.71 - $109.66 $91,407 - $273,053
2,490 Added 18.93%
15,641 $606,000
Q2 2022

Aug 02, 2022

BUY
$35.24 - $47.1 $11,382 - $15,213
323 Added 2.52%
13,151 $490,000
Q1 2022

Apr 27, 2022

SELL
$40.9 - $45.1 $79,714 - $87,899
-1,949 Reduced 13.19%
12,828 $567,000
Q4 2021

Jan 24, 2022

BUY
$38.07 - $44.87 $1,180 - $1,390
31 Added 0.21%
14,777 $628,000
Q3 2021

Oct 21, 2021

BUY
$41.23 - $45.88 $29,768 - $33,125
722 Added 5.15%
14,746 $645,000
Q2 2021

Jul 29, 2021

BUY
$38.58 - $44.24 $7,561 - $8,671
196 Added 1.42%
14,024 $601,000
Q1 2021

May 13, 2021

BUY
$35.27 - $39.67 $13,085 - $14,717
371 Added 2.76%
13,828 $538,000
Q4 2020

Jan 22, 2021

SELL
$33.15 - $41.97 $113,936 - $144,250
-3,437 Reduced 20.34%
13,457 $484,000
Q3 2020

Oct 14, 2020

BUY
$34.44 - $42.23 $84,515 - $103,632
2,454 Added 16.99%
16,894 $649,000
Q2 2020

Aug 06, 2020

BUY
$30.19 - $39.11 $58,236 - $75,443
1,929 Added 15.42%
14,440 $508,000
Q1 2020

Apr 30, 2020

BUY
$25.83 - $45.71 $145,629 - $257,712
5,638 Added 82.03%
12,511 $411,000
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $260,280 - $311,828
6,873 New
6,873 $312,000
Q3 2019

Nov 08, 2019

SELL
$40.31 - $43.45 $214,852 - $231,588
-5,330 Closed
0 $0
Q2 2019

Aug 06, 2019

BUY
$34.91 - $42.98 $186,070 - $229,083
5,330 New
5,330 $229,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.